Medline Inc. Class A Common Stock vs Micron Technology, Inc. — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Micron Technology, Inc. trades at $1,057.88 (market cap $1.23T). The key difference: Micron Technology, Inc. is far larger — about 39.5× Medline Inc. Class A Common Stock's market cap, and Micron Technology, Inc. pays a 0.06% dividend while Medline Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Micron Technology, Inc. for 48 Days on average.
| MDLN | MU | |
|---|---|---|
Market Cap | $31.10B | $1.23T |
Volume | 4,471,639 | 30,214,899 |
Sector | Health | Technology |
52-Week High | $49.99 | $1.21K |
52-Week Low | $31.64 | $181.60 |
Typical Hold Time | 0 Days | 48 Days |
Enterprise Value | $41.07B | $1.19T |
Dividend Yield | — | 0.06% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Micron Technology (MU) trades at $1,035.84, down 0.93% today but remains in a strong uptrend with a 500% gain over the past year. The stock exhibits bullish technical signals, supported by robust fundamentals including a 379% YoY revenue surge in fiscal 2026 and consistent earnings beats. Analyst sentiment is overwhelmingly positive, with 83% recommending Buy, citing AI-driven memory demand and strategic customer agreements securing future revenue.
Outlook: Micron is positioned for sustained growth through 2030 due to AI memory demand and supply constraints, but risks include cyclical slowdowns and valuation sensitivity. The consensus price target of $1,590 implies 53% upside, though high volatility and competitive pressures warrant caution for new investments.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →Micron historically focused on designing and manufacturing DRAM for PCs. The firm then expanded into the NAND flash memory market. It increased its DRAM scale with the purchase of Elpida (completed in mid-2013) and Inotera (completed in December 2016). The firm's DRAM and NAND products tailored to PCs, data centers, smartphones, game consoles, automotives, and other computing devices.
Read more on MU →